An estimated 1 in 3 Americans may carry H. pylori. Most are never investigated beyond digestive complaints.
The standard workup screens H. pylori only when the symptom is digestive. The peer-reviewed literature documents associations across eight conditions — most of which are never tested for it.
Most are asymptomatic and never tested — the carrier rate is the rule, not the exception.
Cite · CDC · Hooi et al. 2017From refractory iron deficiency to chronic urticaria — each with peer-reviewed association literature.
See · The investigation series ↓Acid suppression, nutrient malabsorption, chronic inflammation, molecular mimicry.
Methods · Foundation ProtocolEach guide tags its evidence tier on the cover and inside.
Each guide unpacks the mechanism, the standard workup's blind spot, and the diagnostic steps to rule H. pylori in or out. PDF download via Lemon Squeezy — no subscription, no upsell, no membership wall.
Refractory iron deficiency in adults who absorb fine on paper — what the standard workup overlooks.
Unexplained, post-exertional, "all-labs-normal" fatigue — and the gastric pathway worth ruling out.
Cognitive symptoms with no structural finding — vitamin pathways, inflammation, and the gut–brain axis.
Hashimoto's autoimmunity and the molecular-mimicry hypothesis — the evidence base, plainly graded.
Chronic spontaneous urticaria and the mast cell axis — what an allergist might not order.
Insulin signalling, inflammation, and the case for a gastric workup before the next medication trial.
Low B12 in adults who are supplementing — intrinsic factor, atrophic gastritis, and the workup most miss.
Vasoactive peptides, telangiectasia, and a peer-reviewed link the dermatology workup rarely tests for.
Start with the H. Pylori Overview — a free guide to the diagnostic gap, the four mechanisms, and which conditions to investigate first. PDF, eighteen pages, no upsell.
Single email. Unsubscribe in one click. No partner sharing, ever.
Welyon's investigation is sequenced like a clinical workup. Test for the organism. Read the relevant guide. Engage the supervised protocol — only if indicated.
A non-invasive at-home stool antigen test — the same test gastroenterologists order. Mailed back in the prepaid pouch; results in 5–7 days.
Order the kit · $79 →Match your symptom to one of eight condition guides. Each grades the evidence, names the mechanism, and lists the next clinical questions to bring to a physician.
If the test returns positive and the guide is relevant, you're routed to a physician-supervised treatment protocol — eradication, follow-up testing, and condition-specific monitoring.
A research brand has to be auditable. These are the four artifacts that, together, separate Welyon from a wellness pitch: an advisory board, a registered trial, an evidence grading rubric, and a clear commercial interest disclosure.
Welyon is assembling a scientific advisory board with expertise in gastroenterology, infectious disease, and evidence-based medicine. Advisor names and affiliations will be listed here upon confirmation.
In formation · 2026The Foundation Protocol will be registered on ClinicalTrials.gov prior to commercial availability. Registration ID will appear here, alongside the primary endpoints and the pre-registered analysis plan.
Registration pendingEvery claim across the eight guides is tagged with one of three evidence tiers, defined transparently below. No claim leaves a guide ungraded.
Welyon produces the testing kit and the Foundation Protocol referenced in these guides. The guides are commercial publications. We disclose this on every guide cover, every checkout page, and in the footer of this site. The guides remain the same whether or not you proceed.
Disclosed · Every surfaceA separate page covers the test specifications, the supervised protocol's clinical scaffolding, the evidence base in long form, and the partnership model for primary care, GI, dermatology, and rheumatology practices considering an investigation referral pathway.